Looking at bone marrow under the microscope shows how well the body is making blood. From a small aspirate smear and a core biopsy, a haematologist can judge how many cells the marrow holds, whether each blood-cell family is maturing normally, and whether abnormal cells, scarring or infiltrates have taken over. Those findings give insights into health and disease that a routine blood count cannot. Together with bone marrow histology and modern laboratory tests, it remains one of the most informative investigations in blood medicine.
This guide explains what normal marrow looks like, which changes point to disease, how samples are taken and analysed, and what the results mean for treatment.
What Bone Marrow Looks Like Under the Microscope
Bone marrow is the soft, spongy tissue inside the cavities of bones. In adults, active blood-forming (red) marrow sits mainly in the pelvis, sternum, ribs, skull and vertebrae. Its job is haematopoiesis, the continuous production of red cells, white cells and platelets. You can read more about this in our overview of bone marrow function.
Under the microscope, healthy marrow is a busy mix of cells at every stage of maturity. Several features stand out:
- Erythroid precursors – developing red cells, often in small clusters, with round dark nuclei that shrink as the cell matures.
- Myeloid precursors – developing granulocytes, from early myeloblasts to mature neutrophils with segmented nuclei. These are usually the largest group.
- Megakaryocytes – very large cells with lobed nuclei that shed platelets into the circulation.
- Lymphocytes, plasma cells and macrophages – present in smaller numbers.
- Adipocytes and stromal cells – fat cells and supporting tissue that form the marrow “niche”.
Aspirate Versus Trephine Biopsy
A marrow examination usually has two parts. The aspirate is liquid marrow drawn into a syringe and spread on slides, which shows the detail of individual cells. The trephine biopsy is a small solid core of bone and marrow, which shows the architecture, overall cellularity and any fibrosis or infiltration.
| Feature | Aspirate smear | Trephine biopsy |
|---|---|---|
| Sample type | Liquid marrow spread on slides | Solid core of bone and marrow |
| Best for | Cell shape, differential count, blast percentage | Cellularity, architecture, fibrosis, infiltrates |
| Extra tests | Flow cytometry, cytogenetics, molecular studies | Immunohistochemistry, reticulin stain |
| Turnaround | Often within a day | Several days (the bone must be softened first) |
| Limitation | “Dry tap” if marrow is fibrotic or packed | Less fine cell detail |
Cellularity and the M:E Ratio
Two things I check early are cellularity and the myeloid-to-erythroid (M:E) ratio. Cellularity is the share of marrow space filled by blood-forming cells rather than fat. A common rule of thumb is that it is roughly 100 minus the patient’s age, so it falls as we get older. The normal M:E ratio is about 2:1 to 4:1. A clear shift either way points to a particular kind of problem.
Causes and Mechanisms Behind Abnormal Marrow
Many different processes can upset normal marrow. Inherited conditions such as Fanconi anaemia and acquired conditions such as aplastic anaemia sit within the spectrum of bone marrow failure. Under the microscope these marrows look strikingly empty, with fat replacing blood-forming tissue.
Leukaemias arise from genetic changes that let immature cells (blasts) multiply without maturing. Myeloproliferative neoplasms such as polycythaemia vera and essential thrombocythaemia are often driven by mutations in genes like JAK2, which switch on growth signalling and lead to too many mature cells. Myelodysplastic syndromes produce cells that look abnormal (dysplastic) and die before they are released.
Environmental and Infectious Contributors
Radiation, benzene and other toxic chemicals, chemotherapy and some other medicines can damage marrow. Infections matter too. Parvovirus B19 infects red-cell precursors and can cause a temporary halt in red-cell production, visible as giant early erythroblasts. HIV can suppress the marrow through several routes. Tuberculosis and some fungal infections may form granulomas that show up clearly on a trephine.
Common Microscopic Findings and What They Suggest
Symptoms of bone marrow disorders depend on which cell line is affected. Tiredness points to low red cells, repeated infections to low neutrophils, and easy bruising to low platelets. The marrow slide helps explain why these counts are abnormal.
| Microscopic finding | What it may suggest |
|---|---|
| Hypocellular, fat-replaced marrow | Aplastic anaemia, drug or toxin injury |
| Blasts at 20% or more of marrow cells | Acute leukaemia (WHO threshold for most types) |
| Dysplastic cells, ring sideroblasts | Myelodysplastic syndrome |
| Excess plasma cells | Plasma cell disorders such as myeloma |
| Increased reticulin or collagen fibrosis | Myelofibrosis, some other marrow disorders |
| Absent stainable iron | Iron deficiency |
| Large, oval precursors (megaloblasts) | Vitamin B12 or folate deficiency |
| Granulomas or foreign cells | Infection or cancer spread from elsewhere |
How Samples Are Taken and Analysed
Assessment of bone marrow disorders starts with a full blood count and a blood film. If those raise concern, a bone marrow aspirate and trephine are usually taken from the back of the hip bone (posterior iliac crest) under local anaesthetic. Most patients feel pressure and a short, sharp pull during aspiration, and the procedure takes about 20 to 30 minutes.
The slides are then stained, most often with a Romanowsky stain such as May-Grünwald-Giemsa. A Perls’ stain shows iron stores. The same sample can go for further tests:
- Flow cytometry – uses fluorescent antibodies to identify cell types, classify leukaemia and track minimal residual disease.
- Cytogenetics – looks for chromosomal changes such as translocations or deletions.
- Molecular testing – detects gene mutations that shape diagnosis, prognosis and targeted treatment.
- Immunohistochemistry – stains the trephine to show specific cell populations within the tissue.
Treatment and Management Guided by Marrow Findings
What we see on the slide directly shapes treatment. In acute leukaemia, chemotherapy aims to clear blasts, and a repeat marrow examination checks for remission. Haematopoietic stem cell transplantation can cure some patients by replacing the diseased marrow with healthy donor cells.
Myeloproliferative neoplasms may be managed with venesection (therapeutic phlebotomy), low-dose aspirin, cytoreductive drugs or JAK inhibitors such as ruxolitinib. Aplastic anaemia may be treated with immunosuppressive therapy or transplantation. Nutritional causes respond to replacing iron, B12 or folate. Supportive care, including transfusions and infection prevention, protects patients while the main treatment works.
Key Takeaways
- Examining bone marrow under the microscope shows how blood is made and where that process has gone wrong.
- The aspirate shows individual cells, while the trephine shows structure; together they give the full picture.
- Cellularity, the M:E ratio, blast percentage, iron stores and fibrosis are central findings.
- Flow cytometry, cytogenetics and molecular tests add precision, particularly in leukaemia and bone marrow diseases more generally.
- Marrow examination remains a cornerstone of diagnostic haematology. For a broader introduction, see our bone marrow guide.
Frequently Asked Questions
Is a bone marrow biopsy painful?
The skin and bone surface are numbed with local anaesthetic, so most people feel pressure rather than sharp pain. The aspiration itself can cause a brief, deep pulling sensation. Some soreness at the site for a few days is common and usually eases with simple pain relief.
How long do bone marrow results take?
Aspirate slides can often be reviewed within a day. The trephine takes longer because the bone must be softened before it can be cut and stained. Cytogenetic and molecular results may take one to three weeks, so your haematologist may give a provisional answer first.
What does “hypocellular marrow” mean?
It means the marrow contains fewer blood-forming cells than expected for your age, with more fat taking their place. This may be seen in aplastic anaemia, after chemotherapy or with some toxin exposures. The result is always interpreted together with blood counts and your history.
Can a blood test replace a marrow examination?
A full blood count and blood film often point towards a diagnosis, and some conditions never need a marrow sample. However, when counts are unexplained or leukaemia, myelodysplasia or marrow infiltration is suspected, only direct examination of the marrow can confirm what is happening.
